DENVER – Non-small cell lung cancer (NSCLC) patients with advanced disease receiving standard of care treatment have a higher overall survival (OS) than similar patients not receiving treatment.
Histologic Classification Impacts the Efficacy of SBRT Treatment in Early-Stage Lung Cancer Patients
Early-stage non-small cell lung cancer (NSCLC) patients with squamous cell carcinoma (SqCC) have a significantly higher rate of local failure after stereotactic body radiation therapy (SBRT) than other NSCLC histological subtypes.
This document was created based on the satellite symposium entitled "Evolution of the Individualized Treatment Landscape for Advanced NSCLC." This symposium was held during the IASLC Asia Pacific Lung Cancer Conference (APLCC 2016).
These documents were produced through satellite symposium entitled "Individualizing the Treatment of Advanced NSCLC," held at the IASLC 7th Latin American Conference on Lung Cancer (LALCA 2016).
DENVER – The use of hybrid capture-based (HC-based) next-generation sequencing (NGS) to identify targetable oncogenic drivers in patients with lung adenocarcinoma results in the detection of genomic alterations (GAs) not identified in routine screening, and impacts treatment decisions and clinical outcomes.
DENVER – Preoperative high-intensity interval training (HIIT) in patients with resectable non-small cell lung cancer (NSCLC) improved aerobic performance in patients but failed to reduce early complications after tumor resection.